Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Terns Pharmaceuticals just proved that it's competitive in the weight loss field. Shares of biotechnology companies like Viking Therapeutics (VKTX 6.24%) have exploded upward by over 300% in the last 12 months, thanks to its phenomenal clinical data from its late-stage weight loss drug program. The biotech industry is frequently rife with exciting opportunities for the more risk-tolerant investors, and it should come as no surprise that investors who missed the Viking rally may be looking for a similar oppo ...